Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13624651 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3TDP1L3MBTL1 | |
| SCHEMBL13611335 | 0.92 | PTPN1 (0.40) | L3MBTL1MAPTALDH1A1TSHRPTPN1 | |
| SCHEMBL14802505 | 0.87 | PTPN1 (0.33) | KMT2AALDH1A1MEN1SMN1; SMN2PTPN1 | |
| SCHEMBL13624643 | 0.86 | TDP1 (0.46) | ADRB2ADRB1ADRB3TDP1L3MBTL1 | |
| SCHEMBL13624646 | 0.84 | TDP1 (0.44) | ADRB2ADRB1ADRB3TDP1L3MBTL1 | |
| SCHEMBL13611320 | 0.76 | TSHR (0.41) | TDP1L3MBTL1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL13611354 | 0.74 | PRSS1 (0.47) | TDP1L3MBTL1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL13611326 | 0.74 | PRSS1 (0.45) | TDP1L3MBTL1KMT2AMAPTALDH1A1 | |
| SCHEMBL13624641 | 0.74 | ADRB2 (0.44) | ADRB2ADRB1ADRB3TDP1L3MBTL1 | |
| SCHEMBL13611328 | 0.73 | SERPINE1 (0.40) | TDP1L3MBTL1MAPTALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090292029-A1 | BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF | BEZWADA BIOMEDICAL, L.L.C (US) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292029-A1 | BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF | PUF60, PFAS, UROD | ADRB2 2547/4885ADRB1 2775/4885ADRB3 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.